Meridian Bioscience, Inc. (VIVO)
Jan 31, 2023 - VIVO was delisted (reason: acquired by SD Biosensor and SJL Partners)
33.97
0.00 (0.00%)
Last trade price
Income Statement (Annual)
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 1995 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
|
333.02 | 317.9 | 253.67 | 201.01 | 213.57 | 200.77 | 196.08 | 194.83 | 188.83 | 188.69 | Upgrade
|
Revenue Growth (YoY)
|
4.76% | 25.32% | 26.19% | -5.88% | 6.38% | 2.39% | 0.64% | 3.18% | 0.08% | 9.25% | Upgrade
|
Cost of Revenue
|
144.66 | 116.75 | 97.42 | 82.29 | 82.54 | 76.48 | 68.87 | 72.95 | 71.59 | 67.64 | Upgrade
|
Gross Profit
|
188.36 | 201.15 | 156.25 | 118.73 | 131.03 | 124.29 | 127.21 | 121.88 | 117.24 | 121.04 | Upgrade
|
Selling, General & Admin
|
88.42 | 76.32 | 70.83 | 62.04 | 69.79 | 63.48 | 59.49 | 53.22 | 52.3 | 52.94 | Upgrade
|
Research & Development
|
24.34 | 23.91 | 23.73 | 17.76 | 16.61 | 16.04 | 14.19 | 12.61 | 12.55 | 10.79 | Upgrade
|
Other Operating Expenses
|
21.21 | 7.88 | 0.36 | 6.23 | 13.05 | 7.39 | 2.16 | 0 | 0 | 0 | Upgrade
|
Operating Expenses
|
133.97 | 108.11 | 94.92 | 86.03 | 99.45 | 86.91 | 75.83 | 65.82 | 64.85 | 63.73 | Upgrade
|
Operating Income
|
54.39 | 93.03 | 61.32 | 32.7 | 31.58 | 37.38 | 51.38 | 56.06 | 52.39 | 57.31 | Upgrade
|
Interest Expense / Income
|
1.19 | 1.88 | 2.63 | 1.95 | 1.52 | 1.64 | 0.9 | 0 | 0 | 0 | Upgrade
|
Other Expense / Income
|
-1.12 | 0.71 | -0.6 | -0.8 | -0.32 | -0.69 | -0.16 | 1 | 0.28 | -0.05 | Upgrade
|
Pretax Income
|
54.32 | 90.45 | 59.29 | 31.56 | 30.38 | 36.43 | 50.64 | 55.06 | 52.11 | 57.36 | Upgrade
|
Income Tax
|
11.86 | 19.04 | 13.11 | 7.18 | 6.53 | 14.87 | 18.42 | 19.52 | 17.37 | 19.33 | Upgrade
|
Net Income
|
42.46 | 71.41 | 46.19 | 24.38 | 23.85 | 21.56 | 32.23 | 35.54 | 34.74 | 38.03 | Upgrade
|
Net Income Growth
|
-40.54% | 54.61% | 89.43% | 2.23% | 10.63% | -33.11% | -9.32% | 2.29% | -8.65% | 13.97% | Upgrade
|
Shares Outstanding (Basic)
|
44 | 43 | 43 | 43 | 42 | 42 | 42 | 42 | 41 | 41 | Upgrade
|
Shares Outstanding (Diluted)
|
44 | 44 | 43 | 43 | 43 | 43 | 42 | 42 | 42 | 42 | Upgrade
|
Shares Change
|
0.82% | 1.94% | 0.64% | 0.34% | 0.43% | 0.42% | 0.91% | 0.24% | 0.04% | 0.69% | Upgrade
|
EPS (Basic)
|
0.97 | 1.65 | 1.08 | 0.57 | 0.56 | 0.51 | 0.77 | 0.85 | 0.84 | 0.92 | Upgrade
|
EPS (Diluted)
|
0.96 | 1.62 | 1.07 | 0.57 | 0.56 | 0.51 | 0.76 | 0.85 | 0.83 | 0.91 | Upgrade
|
EPS Growth
|
-40.74% | 51.40% | 87.72% | 1.79% | 9.80% | -32.89% | -10.59% | 2.41% | -8.79% | 13.75% | Upgrade
|
Free Cash Flow Per Share
|
1.69 | 1.12 | 1.04 | 0.78 | 0.72 | 0.87 | 0.79 | 0.94 | 0.80 | 1.00 | Upgrade
|
Dividend Per Share
|
- | - | - | 0.250 | 0.500 | 0.575 | 0.800 | 0.800 | 0.790 | 0.760 | Upgrade
|
Dividend Growth
|
- | - | - | -50.00% | -13.04% | -28.13% | - | 1.27% | 3.95% | - | Upgrade
|
Gross Margin
|
56.56% | 63.27% | 61.60% | 59.06% | 61.35% | 61.91% | 64.88% | 62.56% | 62.09% | 64.15% | Upgrade
|
Operating Margin
|
16.33% | 29.27% | 24.18% | 16.27% | 14.79% | 18.62% | 26.20% | 28.77% | 27.75% | 30.38% | Upgrade
|
Profit Margin
|
12.75% | 22.46% | 18.21% | 12.13% | 11.17% | 10.74% | 16.44% | 18.24% | 18.40% | 20.16% | Upgrade
|
Free Cash Flow Margin
|
22.14% | 15.27% | 17.61% | 16.44% | 14.32% | 18.37% | 16.94% | 20.19% | 17.45% | 21.84% | Upgrade
|
Effective Tax Rate
|
21.83% | 21.05% | 22.11% | 22.74% | 21.50% | 40.82% | 36.36% | 35.46% | 33.33% | 33.70% | Upgrade
|
EBITDA
|
72.02 | 107.62 | 75.49 | 43.47 | 39.82 | 46.19 | 58.17 | 60.28 | 57.67 | 62.99 | Upgrade
|
EBITDA Margin
|
21.63% | 33.85% | 29.76% | 21.62% | 18.65% | 23.01% | 29.67% | 30.94% | 30.54% | 33.38% | Upgrade
|
Depreciation & Amortization
|
16.51 | 15.29 | 13.57 | 9.96 | 7.92 | 8.12 | 6.63 | 5.22 | 5.56 | 5.62 | Upgrade
|
EBIT
|
55.51 | 92.33 | 61.93 | 33.5 | 31.9 | 38.07 | 51.54 | 55.06 | 52.11 | 57.36 | Upgrade
|
EBIT Margin
|
16.67% | 29.04% | 24.41% | 16.67% | 14.94% | 18.96% | 26.29% | 28.26% | 27.59% | 30.40% | Upgrade
|
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).